Literature DB >> 7683665

Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII.

K Miyazawa1, T Shimomura, A Kitamura, J Kondo, Y Morimoto, N Kitamura.   

Abstract

Hepatocyte growth factor (HGF) is a potent mitogen for parenchymal liver cells, epithelial cells, and endothelial cells and may play an important role in liver regeneration following hepatic injury. HGF is homologous to plasminogen and is first synthesized and secreted as an inactive single-chain precursor and then activated to a heterodimeric form by endoproteolytic processing. Recently, a novel serine protease responsible for this processing (HGF activator) has been purified from fetal bovine serum (Shimomura, T., Ochiai, M., Kondo, J., and Morimoto, Y. (1992) Cytotechnology 8, 219-229). In this study, we purified HGF activator from human serum and determined its partial amino acid sequence. Based on the amino acid sequence, we have molecularly cloned the cDNA for human HGF activator. The nucleotide sequence of the cDNA revealed that HGF activator is derived from the COOH-terminal half region of a precursor protein of 655 amino acids and that the precursor consists of multiple putative domains homologous to those observed in blood coagulation factor XII. These domains may be involved in the conversion of the precursor to the active form of HGF activator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683665

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles.

Authors:  O A Ozhogina; M Trexler; L Bányai; M Llinás; L Patthy
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

2.  Signal peptide prediction based on analysis of experimentally verified cleavage sites.

Authors:  Zemin Zhang; William J Henzel
Journal:  Protein Sci       Date:  2004-08-31       Impact factor: 6.725

3.  Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.

Authors:  Hiroyuki Tanaka; Koki Nagaike; Naoki Takeda; Hiroshi Itoh; Kazuyo Kohama; Tsuyoshi Fukushima; Shiro Miyata; Shuichiro Uchiyama; Shunro Uchinokura; Takeshi Shimomura; Keiji Miyazawa; Naomi Kitamura; Gen Yamada; Hiroaki Kataoka
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

5.  Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.

Authors:  Yuka Miyake; Satoshi Tsuzuki; Makoto Yasumoto; Tohru Fushiki; Kuniyo Inouye
Journal:  Cytotechnology       Date:  2009-08-05       Impact factor: 2.058

6.  Factor XII inhibition reduces thrombus formation in a primate thrombosis model.

Authors:  Anton Matafonov; Philberta Y Leung; Adam E Gailani; Stephanie L Grach; Cristina Puy; Qiufang Cheng; Mao-Fu Sun; Owen J T McCarty; Erik I Tucker; Hiroaki Kataoka; Thomas Renné; James H Morrissey; Andras Gruber; David Gailani
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

7.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

Review 8.  Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.

Authors:  Hiroshi Itoh; Hiroaki Kataoka
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 9.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 10.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.